CStone Pharmaceuticals (CSPHF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.66 Billion CNY | 1.44% |
| 2022 | 1.63 Billion CNY | -27.87% |
| 2021 | 2.27 Billion CNY | -39.63% |
| 2020 | 3.76 Billion CNY | 27.52% |
| 2019 | 2.95 Billion CNY | 80.79% |
| 2018 | 1.63 Billion CNY | 189.24% |
| 2017 | 564.28 Million CNY | -31.7% |
| 2016 | 826.13 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.53 Billion CNY | 0.0% |
| 2024 Q1 | 1.53 Billion CNY | -7.82% |
| 2023 Q3 | 1.66 Billion CNY | 0.14% |
| 2023 FY | 1.66 Billion CNY | 1.44% |
| 2023 Q1 | 1.65 Billion CNY | 1.3% |
| 2023 Q4 | 1.66 Billion CNY | 0.0% |
| 2023 Q2 | 1.65 Billion CNY | 0.0% |
| 2022 Q1 | 2.01 Billion CNY | -11.3% |
| 2022 Q4 | 1.63 Billion CNY | 0.0% |
| 2022 Q2 | 2.01 Billion CNY | 0.0% |
| 2022 FY | 1.63 Billion CNY | -27.87% |
| 2022 Q3 | 1.63 Billion CNY | -18.68% |
| 2021 Q1 | 2.89 Billion CNY | -23.16% |
| 2021 FY | 2.27 Billion CNY | -39.63% |
| 2021 Q4 | 2.27 Billion CNY | 0.0% |
| 2021 Q3 | 2.27 Billion CNY | -21.44% |
| 2021 Q2 | 2.89 Billion CNY | 0.0% |
| 2020 Q2 | 2.33 Billion CNY | 0.0% |
| 2020 Q1 | 2.33 Billion CNY | -20.92% |
| 2020 FY | 3.76 Billion CNY | 27.52% |
| 2020 Q4 | 3.76 Billion CNY | 0.0% |
| 2020 Q3 | 3.76 Billion CNY | 61.26% |
| 2019 Q3 | 2.95 Billion CNY | -14.28% |
| 2019 FY | 2.95 Billion CNY | 80.79% |
| 2019 Q2 | 3.44 Billion CNY | 0.0% |
| 2019 Q1 | 3.44 Billion CNY | 110.89% |
| 2019 Q4 | 2.95 Billion CNY | 0.0% |
| 2018 Q4 | 1.63 Billion CNY | -7.53% |
| 2018 FY | 1.63 Billion CNY | 189.24% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q3 | 1.76 Billion CNY | 0.0% |
| 2017 Q4 | 564.28 Million CNY | 0.0% |
| 2017 FY | 564.28 Million CNY | -31.7% |
| 2016 FY | 826.13 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -4178.32% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -22920.136% |
| SQZ Biotechnologies Company | 107.18 Million USD | -1450.56% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -15647.574% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -1176.392% |
| Mesoblast Limited | 667.9 Million USD | -148.839% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -2296589.007% |
| Genus plc | 1.02 Billion USD | -61.532% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -122253.983% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -332939.903% |
| Marizyme, Inc. | 22.01 Million USD | -7449.368% |
| ContraFect Corporation | 20.67 Million USD | -7937.134% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -264971.611% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -425654.036% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -434776.772% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -115958.789% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -39986.594% |
| MultiCell Technologies, Inc. | 126.22 USD | -1316747642.038% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -176766.921% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -1193.284% |
| EV Biologics, Inc. | 431.71 Thousand USD | -384876.86% |
| Q BioMed Inc. | 3.51 Million USD | -47176.091% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -4624.407% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -215563.653% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -636006.125% |
| Biomind Labs Inc. | 73.81 Thousand USD | -2251351.523% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -259.076% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -5437.237% |
| Skye Bioscience, Inc. | 11.94 Million USD | -13819.11% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -50065.801% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -60416.98% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -84774.289% |
| IMV Inc. | 31.33 Million USD | -5204.175% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -241650.232% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -63744.559% |
| GB Sciences, Inc. | 103.44 Thousand USD | -1606596.506% |
| Alpha Cognition Inc. | 2.45 Million USD | -67676.663% |
| HST Global, Inc. | 1526.00 USD | -108912023.198% |
| CSL Limited | 38.02 Billion USD | 95.629% |
| Halberd Corporation | 10.13 Thousand USD | -16404983.407% |
| Enzolytics Inc. | 361.7 Million USD | -359.488% |
| Resverlogix Corp. | 8.11 Million USD | -20380.579% |
| Affymax, Inc. | 7.44 Million USD | -22229.692% |
| SYBLEU INC | 330.46 Thousand USD | -502822.825% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -88404.005% |
| argenx SE | 4.54 Billion USD | 63.412% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -5847.606% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -3384.129% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -7295448.922% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -18471.575% |
| AVAX Technologies, Inc. | 7.37 Million USD | -22428.991% |
| Zenith Capital Corp. | 7410.00 USD | -22429036.302% |
| Genscript Biotech Corporation | 3.38 Billion USD | 50.921% |
| Ember Therapeutics, Inc. | 184.00 USD | -903260226.087% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -516359.917% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -635794.385% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -272.388% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -114612.153% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -54840.554% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -3053.638% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -179002.247% |
| BioStem Technologies, Inc. | 14.56 Million USD | -11314.6% |
| ONE Bio Corp. | 70.08 Million USD | -2271.388% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -2910887.144% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -71947908.658% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -168124.141% |
| Agentix Corp. | 261.39 Thousand USD | -635726.269% |
| LadRx Corporation | 2.3 Million USD | -71914.037% |
| Cell Source, Inc. | 195.17 Thousand USD | -851460.426% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -345748.463% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -469899.745% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -469899.745% |
| NovAccess Global Inc. | 62.24 Thousand USD | -2669863.694% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -259727.001% |
| Itoco Inc. | 1.4 Million USD | -118608.109% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -1737356.747% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -1567823.585% |
| Kadimastem Ltd | 2.3 Million USD | -72032.869% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -2176601.941% |
| CytoDyn Inc. | 11.13 Million USD | -14824.56% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -1162364.678% |
| Mobile Lads Corp. | 52.00 USD | -3196151823.077% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -9295196.421% |
| Qrons Inc. | 420.00 USD | -395713947.619% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -431060.58% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -300921.336% |
| Rebus Holdings, Inc. | 5000.00 USD | -33239880.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -405837.883% |
| International Stem Cell Corporation | 5.39 Million USD | -30734.861% |
| Bioxytran, Inc. | 137.63 Thousand USD | -1207414.64% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -10978.642% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -9924.724% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -2103696.203% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -192110.386% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -22009.871% |
| Neutra Corp. | 2851.00 USD | -58295199.895% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -5028.677% |
| PureTech Health plc | 693.97 Million USD | -139.49% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -20492.004% |
| IXICO plc | 15.84 Million USD | -10389.833% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -19967.604% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -1508.531% |
| CSL Limited | 38.02 Billion USD | 95.629% |
| Cellectis S.A. | 333.99 Million USD | -397.612% |